by Richard @ Bizmarts – May 12th, 2016
We have all seen the articles online suggesting marijuana is useful in the treatment of cancer. It even generated a meme on the Internet about Willie Nelson and former President Carter. Evidence exists that forgoing chemo/radiation and smoking pot instead, for many loci of cancer, could make the last years more worthwhile, less painful, draining, and in many cases the survival duration would be the same or slightly longer. Pot has -not- been proven to -kill- cancer – but it certainly can be used to offset the effects of the malignancy.
The medical industry has lots of disincentives regarding objective truths, especially unpleasant ones, such as being straight-up with cancer patients, and the elderly – which can be perceived by patients as grounds for being suspicious of provider orientation, treatment options, and even intent. The industry needs to be coerced into doing a much better job with end-of-life care and terminal illnesses/disease. Currently the typical person in America spends over 70% of all their medical outlays during the last year of life. That’s nuts !!!
There is one other element in this package that needs to be considered: the incidence of medical malpractice, malfeasance, and error that occurs during treatment. In fact according to a report in the NBCI regarding ‘adverse effects’ in treatment facilities: “Deaths due to preventable adverse events (during treatment) exceed the deaths attributable to motor vehicle accidents (43,458), breast cancer (42,297) or AIDS (16,516). 5“ The report also addresses ‘adverse effects’ from related procedures:
“Hospital patients represent only a fraction of the total population at risk of experiencing a medication-related error. In 1998, nearly 2.5 billion prescriptions were dispensed by U.S. pharmacies at a cost of about $92 billion. 13Numerous studies document errors in prescribing medications, 14 , 15 dispensing by pharmacists, 16 and unintentional nonadherence on the part of the patient. 17 Medication errors have the potential to increase as a major contributor to avoidable morbidity and mortality as new medications are introduced for a wider range of indications.”
Thus it is wise for anyone enmeshed in end-of-life, cancer, or terminal illness cases to carefully examine all evidence, options, and ramifications before simply submitting to the presentations of a health care provider. Additionally one should study the data from non-affiliated medical specialists who do not have evident ‘skin-in-the-game’. The following is a worthy article in that regard.